Anti-lactoferrin antibodies and other types of anti-neutrophil cytoplasmic antibodies (ANCA) in reactive arthritis and ankylosing spondylitis

Clinical and Experimental Immunology

Volumn 117, Issue 3, 1999, Pages 568-573

  Locht, Henning ^a,b   Skogh, T ^a   Kihlstrom E ^a  

^a LINKÖPING UNIVERSITY   (Sweden)

^b STATENS SERUM INSTITUT   (Denmark)

Author keywords

Ankylosing spondylitis; Anti neutrophil cytoplasmic antibodies; Reactive arthritis

Indexed keywords

AUTOANTIBODY; BACTERIAL ANTIGEN; LACTOFERRIN ANTIBODY; NEUTROPHIL CYTOPLASMIC ANTIBODY; UNCLASSIFIED DRUG;

ADULT; ANKYLOSING SPONDYLITIS; ANTIGEN RECOGNITION; ARTICLE; AUTOIMMUNITY; CONTROLLED STUDY; CROSS REACTION; FEMALE; HUMAN; IMMUNOPATHOGENESIS; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; REACTIVE ARTHRITIS; SACROILIITIS; SALMONELLA; YERSINIA;

ADULT; ANIMALS; ANTIBODIES, ANTINEUTROPHIL CYTOPLASMIC; ARTHRITIS, REACTIVE; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; IMMUNOBLOTTING; LACTOFERRIN; MALE; MIDDLE AGED; PEROXIDASE; RABBITS; SPONDYLITIS, ANKYLOSING;

EID: 0032786797     PISSN: 00099104     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2249.1999.01008.x     Document Type: Article

References (32)

1. 1 Schultz DR, Tozman EC. Antineutrophil cytoplasmic antibodies. Major autoantigens, pathophysiology and disease associations. Sem Arthritis Rheum 1995; 25:143-59.
2. 2 Falk RJ, Jennette JC. Antineutrophil cytoplasmic autoantibodies with specificity for myeloperoxidasce in patients with systemic vasculitis and idiopathic necrotizing and crescentic glomerulonephritis. N Engl J Med 1988; 318:1651-7.
3. 3 Gross WL, Csernok E, Flesch K. Classic anti-neutrophil cytoplasmic autoantibodies (cANCA), 'Wegener's autoantigen' and their immonopathogenetic role in Wegever's granulomatosis. J Autoimmun 1993; 3:171-84.
4. 4 Skogh T, Dahlgren C, Holmgren K, Peen E, Stendahl O. Anti-granulocyte antibodies (C-ANCA, P-ANCA, GS-ANA) studied by confocal scanning laser fluorescence microscopy, ELISA and chemiluminescence techniques, Scand J Immunol 1991; 34:137-45.
5. 5 Coremans IEM, Hagen EC, Daha MR et al. Antilactoferrin antibodies in patients with rheumatoid arthritis are associated with vasculitis. Arthritis Rheum 1992; 35:1466-75.
6. 6 Schnabel A, Csernok E, Isenberg D, Mrowka C, Gross WR. Antineutrophil cytoplasmic antibodies in systemic lupus erythematosus. Arthritis Rheum 1995; 38:633-7.
7. 7 Peen E, Almer S, Bodemar G, Ryden B-O, Sjölin C, Tejle K, Skoph T. Antilactoferrin antibodies and other types of ANCA in ulcerative colitis, primary sclerosing cholangitis, and Crohn's disease. Gut 1993; 34:56-62.
8. 8 Cramer E, Pryzwansky KB, Villeval JL, Testa U, Breton Gorius J. Ultrastructual localization of lactoferrin and myeloperoxidase in human neutrophils by immunogold. Blood 1985; 65:423-32.
9. 9 Lash JA, Coates D, Lfuze J, Baehner RL, Boxer LA. Plasma lactoferrin reflects granulocyte activation in vivo. Blood 1983; 61:885-8.
10. 10 Akin DT, Lu MQ, Lu SJ, Kendall S, Arnold RR. Bactericidal activities of different forms of lactoferrin. Adv Exp Med Biol 1994; 357:61-70.
11. 11 Ellison RT III. The effect of lactoferrin on gram negative bacteria. Adv Exp Med Biol 1994; 357:71-90.
12. 12 Appelmelk BJ, An YQ, Gecrts M et al. Lactoferrrin is a lipid A binding protein. Infect Immun 1994; 62:2628-32.
13. 13 Britigan BE, Jonathan S, Serody S, Cohen MS. The role of lactoferrin as an anti-inflammatory molecule. Adv Exp Med Biol 1994; 357:143-56.
14. 14 Britigan BE, Hassett DJ, Rosen CM, Hamill DR, Cohen MS. Neutrophil degranulation inhibits potential hydroxyl-radical formation. Biochem J 1989; 264:447-55.
15. 15 Rosenberg JN, Johnson GD, Holborow EJ. Antinuclear antibodies in ankylosing spondylitis, psoriatic arthritis, and psoriasis. Ann Rheum Dis 1979; 38:526-8.
16. 16 Locht H, Peen E, Skogh T. Antineutrophil cytoplasmic antibodies in reactive arthritis. J Rheumatol 1995; 22:2304-6.
17. 17 Sieper J, Kingsley G. Recent advances in the pathogenesis of reactive arthritis. Immunol Today 1996; 17:160-3.
18. 18 Davenport A. 'False positive' perinuclear and cytoplasmic antineutrophil cytoplasmic antibody results leading to misdiagnosis of Wegener's granulomatosis and/or microscopic polyarteritis. Clin Nephrol 1992; 37:124-30.
19. 19 Klaassen RJL, Goldschmeding R, Dolman KN et all. Antineutrophil cytoplasmic autoantibodies in patients with systemic HIV infection. Clin Exp Immunol 1992; 87:24-30.
20. 20 Yahya TM, Benedict S, Shalabi A, Bayoumi R. Anti-neutrophil cytoplasmic antibody (ANCA) in malaria is directed against cathepsin G. Clin Exp Immunol 1997; 110:41-44.
21. 21 Ellerbrock PM, Oudkerk Pool M, Ridwan BU et al. Neutrophil cytoplasmic antibodies (pANCA) in ulcerative colitis. J Clin Pathol 1994; 47:257-62.
22. 22 Abad E, Tural C, Mirapeix E, Cuxart A. Relationship between ANCA and clinical activity in inflammatory bowel diseases: variation in prevalence of ANCA and evidence of heterogeneity. J Autoimmun 1997; 10:175-80.
23. 23 Broekroelofs J, Mulder AH, Nelis GF, Westerveld BD, Cohen Tervaert JW, Kallenberg CGM. Anti-neutrophil cytoplasmic antibodies (ANCA) in sera from patients with inflammatory bowel diseases (IBD). Relation to disease pattern and disease activity. Dig Dis Sci 1994; 39:545-9.
24. 24 Kossa K, Coulthart A, Ives CT, Pusey CD, Hodgson HJF. Antigen specificity of circulating anti-neutrophil cytoplasmic antibodies in inflammatory bowel disease. Eur J Gastroenterol Hepatol 1995; 7:783-9.
25. 25 Roozendal C, Zhao MH, Horst G, Lockwood CM, Kleibeuker JH, Limburg PC, Nelis GF, Kallenberg CGM. Catalase and a-enolase: two novel autoantigens in inflammatory bowel disease (IBD). Clin Exp Immunol 1998; 112:10-16.
26. 26 Mielants H, Veys EM, Cuvelier C et al. The evolution of spondylarthropathies in relation to gut histology. II. Histological aspects. J Rheumatol 1995; 22:2273-8.
27. 27 Esagui N, Arguas AP, van Embden JDA, Silva MT. Mycobacteria and human autoimmune disease: direct evidence of cross-reactivity between human lactoferrin and the 65-kilodalton protein of tubercle and leprosy bacilli. Infect Immun 1991; 59:1117-25.
28. 28 Esagui N, Freire O, van Embden JDA, Arguas AP. Lactoferrin triggers in vitro proliferation of T-cells of Lewis rats submitted to mycobacteria-induced adjuvant arthritis. Scand J Immunol 1993; 38:147-52.
29. 29 Schultz DR, Arnold PI. Heat-shock (stress) proteins and autoimmunity in rheumatic diseases. Sem Arthritis Rheum 1993; 22:357-74.
30. 30 Jones DB, Coulson AFW, Duff GW. Sequence homologies between hsp 60 and autoantigens. Immunol Today 1993; 14:115-8.
31. 31 Hajeer AH, Bernstein RM. Antibody to mycobacterial 65-kD heat shock protein in commercial antisera. Clin Exp Immunol 1993; 94:544-7.
32. 32 Peen E, Skogh T, Eneström S. Distribution of lactoferrin and 60/65 heat shock protein in normal and inflamed human intestine and liver. Gut 1996; 38:135-40.